The Valley Desk

NCT06058793 · Interventional trial

Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

Overall registry status Completed

Phase 3

Conditions Liposarcoma, Dedifferentiated

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov